Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenetic Biosciences Inc (NASDAQ:XBIO)

2.26
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.75
Today|||52-Week Range
5.90
-47.44%
Year-to-Date
No recent news for Xenetic Biosciences Inc.

Today’s Trading

Previous close2.26
Today’s open2.27
Day’s range2.26 - 2.28
Volume4,230
Average volume (3 months)19,727
Market cap$19.7M
Dividend yield--
Data as of 3:09pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-163.97%
Earnings growth (this year)+88.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales10.65
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...0.000.00%
AOXGAoxing Pharmaceutica...0.000.00%
HTBXHeat Biologics Inc0.000.00%
DAREDare Bioscience Inc0.000.00%
Data as of 3:59pm ET, 11/22/2017

Financials

Last reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$3.0M
Annual profit (last year)-$54.2M
Net profit margin-1,806.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Director, Chief Executive &
Operating Officer
Jeffrey F. Eisenberg
Secretary, Chief Financial &
Accounting Officer
James F. Parslow
Corporate headquarters
Lexington, Massachusetts

Forecasts